Figure 2.
Impacts of the two major PCBP isoforms, PCBP1 and PCBP2, on CDK2 ex5 splicing. (A) Impact of isoform-specific depletions of PCBP1 and PCBP2 proteins on splicing of exon 5 in the endogenous CDK2 transcript. K562 cells were individually transfected with 2 distinct siRNAs that co-target PCBP1 and PCBP2 mRNAs (siRNA PCBP1/2-1, PCBP1/2-2 as described (19)). The study was done in biological triplicate or with three distinct siRNAs that selectively target PCBP1 (PCBP1-1, PCBP1-2, PCBP1-3), or PCBP2 (PCBP2-1, PCBP2-2, PCBP2-3). Left: Impact of isoform-specific PCBP depletions on cassette exon 5 splicing of the endogenous CDK2 transcript assessed by RT-PCR. Right: Quantification and statistics of the cassette exon 5 splicing data. Summary of the splicing inclusion values are shown on the histogram to the right. ∗∗∗P < 0.001, n.s.: not significant. (B) Impacts of PCBP1 and PCBP2 depletion/repletion on CKD2 ex5 mingene splicing. The minigene (CDK2-C13) plasmid was co-transfected into K562 cells along with a control siRNA (CTRL) or a siRNA co-targeting PCBP1/2 (siRNA PCBP1/2-2 as in (19)) and/or with plasmids expressing recombinant Flag-tagged PCBP1 or PCBP2 (encoded by siRNA-immune mRNAs). The experiment was carried out twice (n = 2). Left: Western blot analysis of protein expression. Labeling of lanes: V (empty vector), CP1 (Flag-PCBP1 expression vector), and CP2 (Flag-PCBP2 expression vector). Western blot assay confirmed siRNA-mediated depletion of endogenous PCBP1 or PCBP2 and expression of the recombinant Flag-PCBP proteins. Right: Impacts of depletion and repletion on CDK2 ex5 minigene splicing. The mean level of exon 5 inclusion (±SD) in each transfection is displayed below the corresponding lane (n = 2). ∗P < 0.05, ∗∗P < 0.01, n.s.: not significant.